Identification of vitronectin as a potential non-invasive biomarker of metastatic breast cancer using a label-free LC-MS/MS approach.

Of the five biomarkers initially tested, since analysis indicated statistically significant differences in VTN and TN and an increasing trend in ZAG, these were then tested in the next phase of training and validation in a larger cohort of samples including HC, MBC as well as samples from patients with IBC.

also in 63,971 other papers